Position in ALKS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$9,954,899
+$4,304,690 QoQ
Shares Held
189,979
+18.9% QoQ
Ownership
0.113%
of shares outstanding
% of Portfolio
1.62%
of 13F equity value
Holder Rank
#95
of 424 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Tetragon Partners GP Ltd holds $15,305,649 across 2 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (65.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALKS |
Alkermes plc.
This page
|
189,979 | $9,954,899 | |
| 2 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
297,926 | $5,350,750 |
All Filings in ALKS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,954,899 | 189,979 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $5,650,209 | 159,791 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,949,992 | 141,172 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,688,360 | 89,612 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $447,231 | 15,632 | Shares | Defined | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||